What drove the RGS.AX stock move after hours on 18 Feb 2026?

The after hours move was volume-driven: RGS.AX stock rose to A$0.012 on **4,275,678** shares traded, about 6.93 times average volume. Traders reacted to clinical and company news momentum while liquidity spiked.

What is Meyka AI’s view on RGS.AX stock performance?

Meyka AI rates RGS.AX **64.82/100** (Grade B, HOLD). The model shows catalyst-driven upside but highlights cash-flow and dilution risk for longer-term investors in RGS.AX stock.

What price target and upside does Meyka AI give for RGS.AX stock?

Meyka AI's forecast model projects a reference target of **A$0.020**, implying **66.67%** upside from the current **A$0.012**. Forecasts are model projections and not guarantees.

What are the main risks for RGS.AX stock investors?

Key risks include negative operating cash flow, low current ratio (0.28), potential dilution, and small market cap (A$3,677,244.00). These raise liquidity and execution risk for RGS.AX stock positions.

AU Stocks

RGS.AX Regeneus Ltd ASX up 33.33% after hours 18 Feb 2026: high-volume breakout

ByDanny Kontos February 18, 2026February 18, 2026

RGS.AX stock moved sharply in after hours trade on 18 Feb 2026, rising to A$0.012 (+33.33%) on unusually high turnover. Volume reached 4,275,678 shares, nearly seven times average, signalling active trader interest in Regeneus Ltd (RGS.AX) on the ASX. The move came while the Healthcare sector was modestly positive, and follows recent clinical and corporate updates. We use Meyka AI data to connect the surge to fundamentals, volume metrics and short-term technicals for investors watching high-volume movers.